Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Switch Study to Asenapine in the Early Stage of Psychosis

NCT01968161 is registered in ClinicalTrials.gov with Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec as lead sponsor.

NCT NCT01968161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01968161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Switch Study to Asenapine in the Early Stage of Psychosis
Lead sponsor
Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2013
Completion date
March 31, 2014
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorders, schizophrenia and disorders with psychotic features